OVO Biomanufacturing are the world leading experts in providing technical solutions to solve the effects of defective interfering particles for viral vaccine manufacturers.  
 
OVO's novel technology platform offers multi-fold yield improvements by reducing the generation and effect of these particles during all stages of vaccine manufacture. OVO's platform can be used to manage defective interfering particles for both established and developing live attenuated and inactivated viral vaccines. Our platform can be implemented without significantly altering production processes or regulatory compliance.

OVO Biomanufacturing

Org chart

Teams

Offices